Search fresh public links, source activity, and ready-to-use post angles for Rrms.
Fresh curated links around RRMS are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
www.mssociety.org.uk Twitter: @mssocietyuk Primary research areas Neurological Grant types Clinical trial, Early Career Fellowship, Travel and meetings, Postgraduate studen...
A trio of European scientists has linked subtle changes in the brain’s white matter — tissue rich in nerve cell projections — to early relapsing-remitting multiple sclerosis (RRMS)...
Daruwalla et al. Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis. Brain. 2026 Jul 24:awag252. Clinically silent MRI lesions occur...
www.msatrust.org.uk Twitter: @MSAtrust Primary research areas Neurological Grant types Fellowship, Project (typically <4 years) Research stages Discovery/basic research,...
In analyzing brain MRIs on people with early relapsing-remitting multiple sclerosis (RRMS), two markers of ongoing inflammation may help identify those patients at a higher risk of...
People with relapsing-remitting multiple sclerosis (RRMS) who show even a single silent lesion on an MRI scan while taking a lower- or moderate-efficacy disease-modifying therapy (...
www.reverserett.org.uk Twitter: @reverseRett Primary research areas Neurological Grant types Postgraduate studentship, Project (typically <4 years), Programme (typica...
In people with relapsing-remitting multiple sclerosis (RRMS), greater physical disability is associated with poorer cognitive function, while higher levels of formal education are...
Maal AB, Arki MK, Nabavi SM, Rezaei-Tavirani M, Rismani E, Vosough M, Azizi G, Hossein-Khannazer N. Immune reconstitution and tolerance-inducing therapies as promising therapeutic...
An experimental oral drug called remibrutinib outperformed the approved therapy Aubagio (teriflunomide) in reducing disease flare rates in two large, late-stage clinical trials inv...
A trio of scientists in Australia has developed a mathematical model that can be used to help understand disease activity patterns in people with multiple sclerosis (MS). The model...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.